Results 111 to 120 of about 4,080 (215)

Gyógyszer indukált állcsontnekrózis

, 2017
Az antireszorptív és antiangiogén készítmények terápiás előnye messzemenően felülmúlja az esetleges mellékhatások hátrányait, így indikációi (daganatáttétek kezelése, osteoporosis, patológiás frakturák megelőzése) nem kérdőjelezhetőek meg.
Szabadi, László
core  

PRF usage in MRONJ

Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication associated with antiresorptive and antiangiogenic therapies, particularly bisphosphonates and denosumab.
Goodarzian, Amir Reza
core  

EFFICACY OF ADJUNCTIVE PDT IN THE TREATMENT OF A PARTICULAR PRESENTATION OF MRONJ: A CASE REPORT

Background. Drug-related osteonecrosis of the jaw (MRONJ) is an adverse event in patients with osteometabolic and/or oncological disease treated with antiresorptive (pAR) drugs including anti-RANKL antibodies (e.g., denosumab) and nitrogen-containing ...
Mosaico Giovanna, Murgia Martina Salvatorina, Casu Cinzia, Orru Germano   +3 more
core  

Különböző mikrobiológiai hátterű MRONJ-ban szenvedő betegek protetikai ellátása és gondozása

A gyógyszer okozta állcsontelhalás (Medication Related Osteonecrosis of the Jaw, MRONJ) egy multifaktoriális eredetűsúlyos állapot, melynek pontos etiológiai tényezői a mai napig nem tisztázottak.
Lakatos, Flóra Aliz, Schmidt, Péter, Kádár, László, Bródy, Andrea, Kőnig, János, Mensch, Károly   +5 more
core   +1 more source

Utility of quantitative standardized uptake value from pre-operative bone SPECT/CT for predicting post-surgical MRONJ healing response

EJNMMI Research
Background Medication-related osteonecrosis of the jaw (MRONJ) is a challenging condition often associated with long-term use of anti-resorptive medications.
Jung-Hyun Park, Da-Mi Yoon, Hai-Jeon Yoon, Jin-Woo Kim   +3 more
doaj   +1 more source

Hemato-Onkoloji HastalarındaÇenelerin İlaç ile İlişkiliOsteonekrozunun (MRONJ)Konik Işınlı BilgisayarlıTomografi ileDeğerlendirilmesi: Olgu Serisi

Genel olarak antirezorptif ve antianjiyojenik ilaç kullanan hastalarda, çene kemiklerinde dental bir operasyona sekonder gelişebilen osteonekroz (Medication-Related Osteonecrosis of the Jaw, MRONJ) klinik ve radyolojik bulguları olan, nadir ancak ciddi ...
Pamukçu, Umut
core   +1 more source

Lamina dura thickening in patients on antiresorptive therapy as a radiographic risk indicator of medication-related osteonecrosis of the jaw: a retrospective longitudinal cohort study. [PDF]

Dentomaxillofac Radiol
Radi S, El Bachaoui S, Tsiklin I, Pastenes C, De Backer H, Coropciuc R, Van den Wyngaert T, Beuselinck B, Jacobs R.   +8 more
europepmc   +1 more source

Incidence and associated factors of medication-related osteonecrosis of the jaw in breast cancer patients with bone metastases: a nationwide registry study in Finland. [PDF]

Clin Oral Investig
Kujanpää M, Vuollo V, Tiisanoja A, Laitala ML, Koivunen J, Sándor GK, Karki S.   +6 more
europepmc   +1 more source

Oral microbiome and lesion-associated microbiological findings in medication-related osteonecrosis of the jaw: a systematic review and evidence map. [PDF]

Front Cell Infect Microbiol
Yin X, Du S, Wan J.
europepmc   +1 more source

A Retrospective Cohort Study of Medication-Related Osteonecrosis of the Jaw (MRONJ) Prevention. [PDF]

Oral Health Prev Dent
Baghalipour N, Moztarzadeh O, Othman B, Dehghani Y, Hauer L.   +4 more
europepmc   +1 more source